Effect of Sequential vs. Simultaneous Dual Growth Factor Release from Structured Heparin-Poly-Electrolyte Multilayer Coatings on Peri-Implant Bone Formation and Angiogenesis in Pig Mandibles
Source abstract
Abstract
The aim of the present study was to test the sequential and simultaneous release of rhBMP2 and rhVEGF165 from poly-l-lysine-heparin (PLL-Hep) poly-electrolyte multilayer (PEM) coating on titanium surfaces for their ability to enhance peri-implant bone formation and CD31 expression around disc-shaped titanium implants (5 × 7 mm) in mini-pig mandibles. Bare titanium surfaces loaded with respective growth factor combinations served as controls. Ten different surface conditions were tested exhibiting early VEGF release, early BMP release, simultaneous VEGF and BMP release, and sole VEGF/BMP release, respectively. The implants were inserted press-fit into 5 mm trephine cavities at the lower border of the mandibles of mini-pigs and left to heal for 4 and 13 weeks. After 4 weeks, there was no significant difference in peri-implant bone formation, bone–implant contact nor CD31 expression between the different surface conditions. After 13 weeks, bone formation was significantly higher in the zone of 100 μm next to implant surfaces releasing either BMP alone or with an early release of BMP2. Expression of CD31 has significantly decreased from 4 to 13 weeks with significantly higher values in the group of implants with early release of BMP2. The results indicate that the range of released growth factors is limited to a distance of approximately 100 μm and that the sequence of early release of BMP2 followed by VEGF165 promotes peri-implant bone formation and peri-implant angiogenesis, which is in contrast to the current understanding of the temporal patterns of growth factor release for enhancement of bone formation.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Electrospun Nanofibers in Biomedical Applications · Periodontal Regeneration and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Oral and Maxillofacial Surgery, George-Augusta-University, 37075 Gottingen, Germany
Department of Diagnostic and Interventional Radiology, George-Augusta-University, 37075 Gottingen, Germany
Department of Diagnostic and Interventional Radiology, University Hospital Heidelberg, 69120 Heidelberg, Germany
Max Plank Institute for Multidisciplinary Sciences, 37077 Gottingen, Germany
Institute for Bioprocessing and Analytical Measurement Techniques, 37308 Heiligenstadt, Germany
Funding
German Research Foundation (DFG)
References (43)
Show source-provided references
1. Effect of ovarectomy on bone remodelling adjacent to hydroxyapatite-coated implants in the tibia of mature rats10.1053/joms.2000.8212 ↗
2. Bone response to titanium alloy implants placed in diabetic rats
3. Osteoporosis-like bone conditions affect osseointegration of implants
4. Surface-modified titanium and titanium-based alloys for improved osteogenesis: A critical review10.1016/j.heliyon.2023.e23779 ↗
5. Che, Z., Sun, Q., Zhao, Z., Wu, Y., Xing, H., Song, K., Chen, A., Wang, B., and Cai, M. (2024). Growth factor-functionalized titanium implants for enhanced bone regeneration: A review. Int. J. Biol. Macromol., 274.10.1016/j.ijbiomac.2024.133153 ↗
6. Bioactive surface modifications on dental implants: A systematic review and meta-analysis of osseointegration and longevity10.1007/s00784-024-05958-y ↗
7. Meng, H.W., Chien, E.Y., and Chien, H.H. (2016). Dental implant bioactive surface modifications and their effects on osseointegration: A review. Biomark. Res., 4.10.1186/s40364-016-0078-z ↗
8. Osseointegration by bone morphogenetic protein-2 an transforming growth factor beta 2 coated titanium implants in femora of New Zealand white rabbits10.4103/0019-5413.73659 ↗
9. The effect of combined delivery of recombinant human bone morphogenic protein-2 and recombinant human vascular endothelial growth factor 165 from biomimetic calcium-phosphate coated implants10.1111/j.1600-0501.2010.02133.x ↗
10. Alveolar ridge augmentation using implants coated with recombinant human growth/differentiation factor 5 (rhGDF-5). Radiographic observations10.1111/j.1600-0501.2012.02564.x ↗
11. Comparative analysis of osseointegration of titanium implants with acid-etched surfaces and different biomolecular coatings10.1016/j.tripleo.2011.01.004 ↗
12. Safety and efficacy of recombinant human bone morphogenetic protein 2 on cranial defect closure in the pediatric population10.1097/SCS.0b013e318256657c ↗
13. Shweikeh, F., Hanna, G., Bloom, L., Sayegh, E.T., Liu, J., Acosta, F.L., and Drazin, D. (J. Neurosurg. Sci., 2014). Assessment of outcome following the use of recombinant human bone morphogeneticprotein-2 for spinal fusion in the elderly population, J. Neurosurg. Sci., ahead of print.
14. Acute epidural lipedema: A novel entity and potential complication of bonemorphogenetic protein use in lumbar spine fusion10.1016/j.spinee.2013.05.024 ↗
15. Histopathologic inflammatory response induced by recombinant bone morphogeneticprotein-2 causing radiculopathy after transforaminal lumbar interbody fusion10.1016/j.spinee.2010.06.020 ↗
16. Enhanced osteogenic promotion around dental implants with synthetic binding motif mimicking bone morphogenetic protein (BMP)-210.1002/jbm.a.30639 ↗
17. Phosphonic acid monolayers for binding of bioactive molecules to titanium surfaces10.1021/la060754c ↗
18. Effect of oligonucleotide mediated immobilization of bone morphogenic proteins on titanium surfaces—An in vitro study10.1016/j.biomaterials.2011.10.027 ↗
19. Characterization of tunable FGF-2 releasing polyelectrolyte multilayers10.1021/bm100413w ↗
20. Guduru, D., Niepel, M.S., Gonzalez-Garcia, C., Salmeron-Sanchez, M., and Groth, T. (2017). Comparative Study of Osteogenic Activity of Multilayers Made of Synthetic and Biogenic Polyelectrolytes. Macromol. Biosci., 17.10.1002/mabi.201700078 ↗
21. The stability of BMP loaded polyelectrolyte multilayer coatings on titanium10.1016/j.biomaterials.2013.03.067 ↗
22. Polysaccharide-blend multilayers containing hyaluronan and heparin as a delivery system for rhBMP210.1002/smll.200901728 ↗
23. Surface delivery of tunable doses of BMP2 from an adaptable polymeric scaffold induces volumetric bone regeneration10.1016/j.biomaterials.2016.06.001 ↗
24. Ishihara, M., Nakamura, S., Sato, Y., Takayama, T., Fukuda, K., Fujita, M., Murakami, K., and Yokoe, H. (2019). Heparinoid Complex-Based Heparin-Binding Cytokines and Cell Delivery Carriers. Molecules, 24.10.3390/molecules24244630 ↗
25. Stiffness-dependent cellular internalization of matrix-bound BMP-2 and its relation to Smad and non-Smad signalling10.1016/j.actbio.2016.09.014 ↗
26. Polyelectrolyte Multilayers Enhance the Dry Storage and pH Stability of Physically Entrapped Enzymes10.1021/acsami.0c04964 ↗
27. Tunable dual growth factor delivery from polyelectrolyte multilayer films10.1016/j.biomaterials.2011.04.036 ↗
28. Development of a system of heparin multilayers on titanium surfaces for dual growth factor release10.1002/jbm.a.37411 ↗
29. Schirmer, U., Ludolph, J., Rothe, H., Hauptmann, N., Behrens, C., Bittrich, E., Schliephake, H., and Liefeith, K. (2022). Tailored Polyelectrolyte Multilayer Systems by Variation of Polyelectrolyte Composition and EDC/NHS Cross-Linking: Physicochemical Characterization and In Vitro Evaluation. Nanomaterials, 12.10.3390/nano12122054 ↗
30. Animal models for implant biomaterial research in bone: A review10.22203/eCM.v013a01 ↗
31. Percie du Sert, N., Ahluwalia, A., Alam, S., Avey, M.T., Baker, M., Browne, W.J., Clark, A., Cuthill, I.C., Dirnagl, U., and Emerson, M. (2020). Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0. PLoS Biol., 18.10.1371/journal.pbio.3000411 ↗
32. Kauffmann, P., Wolfer, S., Behrens, C., Schlosser, P., Dullin, C., SChirmer, U., Liefeieith, K., and Schliephake, H. (Biomaterials, 2025). Dual growth factor release from collagen based polyelectrolyte multilayer films on Ti-implant enhances periimplant bone formation and angiogenic activity, Biomaterials, submitted.
33. A method for the study of undecalcified bones and teeth with attached soft tissues. The Säge-Schliff (sawing and grinding) technique10.1111/j.1600-0714.1982.tb00172.x ↗
34. Calvarial Bone Regeneration Is Enhanced by Sequential Delivery of FGF-2 and BMP-2 from Layer-by-Layer Coatings with a Biomimetic Calcium Phosphate Barrier Layer10.1089/ten.tea.2017.0111 ↗
35. Biomimetic calcium phosphate/polyelectrolyte multilayer coatings for sequential delivery of multiple biological factors10.1002/jbm.a.35985 ↗
36. Tunable staged release of therapeutics from layer-by-layer coatings with clay interlayer barrier10.1016/j.biomaterials.2013.12.009 ↗
37. Combination Growth Factor Therapy via Electrostatically Assembled Wound Dressings Improves Diabetic Ulcer Healing In Vivo10.1002/adhm.201500403 ↗
38. Liu, X., Liu, W.C., Wang, H.Y., Li, V.L., Chen, Y.C., Wang, A.N., Wu, C.J., Li, Y., Zhao, G., and Lin, C. (2021). Polyelectrolyte multilayer composite coating on 316 L stainless steel for controlled release of dual growth factors accelerating restoration of bone defects. Mater. Sci. Eng. C Mater. Biol. Appl., 126.10.1016/j.msec.2021.112187 ↗
39. Dual-function nanofilm coatings with diffusion control and protein resistance10.1021/am900673r ↗
40. Schultz, R.D., Bennett, E.E., Ellis, E.A., and Gumienny, T.L. (2014). Regulation of extracellular matrix organization by BMP signaling in Caenorhabditis elegans. PLoS ONE, 11.10.1371/journal.pone.0101929 ↗
41. BMP growth factor signaling in a biomechanical context10.1002/biof.1137 ↗
42. Do we need retarded delivery of bone growth factors in facial bone repair? An experimental study in rats10.22203/eCM.v034a11 ↗
43. Bouyer, M., Garot, C., Machillot, P., Vollaire, J., Fitzpatrick, V., Morand, S., Boutonnat, J., Josserand, V., Bettega, G., and Picart, C. (2021). 3D-printed scaffold combined to 2D osteoinductive coatings to repair a critical-size mandibular bone defect. Mater. Today Bio., 11.10.1016/j.mtbio.2021.100113 ↗